nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP2D6—Niacin—atherosclerosis	0.122	0.169	CbGbCtD
Palonosetron—CYP2D6—Simvastatin—atherosclerosis	0.0967	0.134	CbGbCtD
Palonosetron—CYP2D6—Pravastatin—atherosclerosis	0.0946	0.131	CbGbCtD
Palonosetron—CYP2D6—Lovastatin—atherosclerosis	0.0946	0.131	CbGbCtD
Palonosetron—CYP3A4—Rosuvastatin—atherosclerosis	0.0662	0.0916	CbGbCtD
Palonosetron—CYP3A4—Ezetimibe—atherosclerosis	0.0662	0.0916	CbGbCtD
Palonosetron—CYP3A4—Simvastatin—atherosclerosis	0.0615	0.0851	CbGbCtD
Palonosetron—CYP3A4—Pravastatin—atherosclerosis	0.0602	0.0833	CbGbCtD
Palonosetron—CYP3A4—Lovastatin—atherosclerosis	0.0602	0.0833	CbGbCtD
Palonosetron—Distention—Pravastatin—atherosclerosis	0.0103	0.0394	CcSEcCtD
Palonosetron—Generalised oedema—Niacin—atherosclerosis	0.00416	0.0159	CcSEcCtD
Palonosetron—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.0036	0.0137	CcSEcCtD
Palonosetron—Eye irritation—Lovastatin—atherosclerosis	0.00338	0.0129	CcSEcCtD
Palonosetron—Laryngospasm—Niacin—atherosclerosis	0.00332	0.0126	CcSEcCtD
Palonosetron—Amblyopia—Niacin—atherosclerosis	0.00321	0.0122	CcSEcCtD
Palonosetron—Feeling hot—Niacin—atherosclerosis	0.00315	0.012	CcSEcCtD
Palonosetron—Hyperbilirubinaemia—Niacin—atherosclerosis	0.00272	0.0104	CcSEcCtD
Palonosetron—Fluid retention—Niacin—atherosclerosis	0.00235	0.00895	CcSEcCtD
Palonosetron—Hot flush—Ezetimibe—atherosclerosis	0.00219	0.00835	CcSEcCtD
Palonosetron—Menopausal symptoms—Ezetimibe—atherosclerosis	0.00218	0.00828	CcSEcCtD
Palonosetron—Pain in extremity—Lovastatin—atherosclerosis	0.00209	0.00797	CcSEcCtD
Palonosetron—Pain in extremity—Ezetimibe—atherosclerosis	0.00205	0.00782	CcSEcCtD
Palonosetron—Hot flush—Pravastatin—atherosclerosis	0.00189	0.0072	CcSEcCtD
Palonosetron—Menopausal symptoms—Pravastatin—atherosclerosis	0.00188	0.00714	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00185	0.00704	CcSEcCtD
Palonosetron—Gastritis—Ezetimibe—atherosclerosis	0.00182	0.00692	CcSEcCtD
Palonosetron—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.0018	0.00685	CcSEcCtD
Palonosetron—Sinusitis—Rosuvastatin—atherosclerosis	0.00179	0.0068	CcSEcCtD
Palonosetron—Gastritis—Simvastatin—atherosclerosis	0.00173	0.0066	CcSEcCtD
Palonosetron—Urinary retention—Niacin—atherosclerosis	0.00171	0.00651	CcSEcCtD
Palonosetron—Abdominal distension—Niacin—atherosclerosis	0.00156	0.00595	CcSEcCtD
Palonosetron—Abdominal distension—Pravastatin—atherosclerosis	0.00154	0.00586	CcSEcCtD
Palonosetron—Arrhythmia—Rosuvastatin—atherosclerosis	0.00153	0.00581	CcSEcCtD
Palonosetron—Sinusitis—Lovastatin—atherosclerosis	0.00151	0.00576	CcSEcCtD
Palonosetron—Mental disorder—Rosuvastatin—atherosclerosis	0.0015	0.0057	CcSEcCtD
Palonosetron—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.0015	0.0057	CcSEcCtD
Palonosetron—Sinusitis—Ezetimibe—atherosclerosis	0.00148	0.00565	CcSEcCtD
Palonosetron—Flatulence—Rosuvastatin—atherosclerosis	0.00147	0.00558	CcSEcCtD
Palonosetron—Sinusitis—Simvastatin—atherosclerosis	0.00142	0.00539	CcSEcCtD
Palonosetron—Connective tissue disorder—Ezetimibe—atherosclerosis	0.0014	0.00531	CcSEcCtD
Palonosetron—Chills—Lovastatin—atherosclerosis	0.0013	0.00495	CcSEcCtD
Palonosetron—Angiopathy—Ezetimibe—atherosclerosis	0.00129	0.00491	CcSEcCtD
Palonosetron—Immune system disorder—Ezetimibe—atherosclerosis	0.00128	0.00488	CcSEcCtD
Palonosetron—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00128	0.00487	CcSEcCtD
Palonosetron—Sinusitis—Pravastatin—atherosclerosis	0.00128	0.00487	CcSEcCtD
Palonosetron—Alopecia—Lovastatin—atherosclerosis	0.00128	0.00487	CcSEcCtD
Palonosetron—Arthralgia—Rosuvastatin—atherosclerosis	0.00127	0.00482	CcSEcCtD
Palonosetron—Myalgia—Rosuvastatin—atherosclerosis	0.00127	0.00482	CcSEcCtD
Palonosetron—Alopecia—Ezetimibe—atherosclerosis	0.00125	0.00478	CcSEcCtD
Palonosetron—Mental disorder—Ezetimibe—atherosclerosis	0.00124	0.00474	CcSEcCtD
Palonosetron—Flatulence—Lovastatin—atherosclerosis	0.00124	0.00473	CcSEcCtD
Palonosetron—Malnutrition—Ezetimibe—atherosclerosis	0.00124	0.00471	CcSEcCtD
Palonosetron—Erythema—Ezetimibe—atherosclerosis	0.00124	0.00471	CcSEcCtD
Palonosetron—Dysgeusia—Lovastatin—atherosclerosis	0.00123	0.0047	CcSEcCtD
Palonosetron—Flatulence—Ezetimibe—atherosclerosis	0.00122	0.00464	CcSEcCtD
Palonosetron—Chills—Simvastatin—atherosclerosis	0.00121	0.00463	CcSEcCtD
Palonosetron—Infection—Rosuvastatin—atherosclerosis	0.00121	0.00459	CcSEcCtD
Palonosetron—Alopecia—Simvastatin—atherosclerosis	0.0012	0.00456	CcSEcCtD
Palonosetron—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00119	0.00453	CcSEcCtD
Palonosetron—Mental disorder—Simvastatin—atherosclerosis	0.00119	0.00452	CcSEcCtD
Palonosetron—Erythema—Simvastatin—atherosclerosis	0.00118	0.00449	CcSEcCtD
Palonosetron—Eye disorder—Niacin—atherosclerosis	0.00116	0.00442	CcSEcCtD
Palonosetron—Flatulence—Simvastatin—atherosclerosis	0.00116	0.00442	CcSEcCtD
Palonosetron—Tinnitus—Niacin—atherosclerosis	0.00116	0.00441	CcSEcCtD
Palonosetron—Dysgeusia—Simvastatin—atherosclerosis	0.00115	0.0044	CcSEcCtD
Palonosetron—Anaemia—Ezetimibe—atherosclerosis	0.00114	0.00435	CcSEcCtD
Palonosetron—Tinnitus—Pravastatin—atherosclerosis	0.00114	0.00435	CcSEcCtD
Palonosetron—Cardiac disorder—Pravastatin—atherosclerosis	0.00114	0.00433	CcSEcCtD
Palonosetron—Angiopathy—Niacin—atherosclerosis	0.00113	0.0043	CcSEcCtD
Palonosetron—Chills—Niacin—atherosclerosis	0.00112	0.00425	CcSEcCtD
Palonosetron—Arrhythmia—Niacin—atherosclerosis	0.00111	0.00423	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00111	0.00421	CcSEcCtD
Palonosetron—Alopecia—Niacin—atherosclerosis	0.0011	0.00418	CcSEcCtD
Palonosetron—Chills—Pravastatin—atherosclerosis	0.0011	0.00418	CcSEcCtD
Palonosetron—Insomnia—Rosuvastatin—atherosclerosis	0.0011	0.00418	CcSEcCtD
Palonosetron—Arrhythmia—Pravastatin—atherosclerosis	0.00109	0.00416	CcSEcCtD
Palonosetron—Paraesthesia—Rosuvastatin—atherosclerosis	0.00109	0.00415	CcSEcCtD
Palonosetron—Anaemia—Simvastatin—atherosclerosis	0.00109	0.00415	CcSEcCtD
Palonosetron—Malnutrition—Niacin—atherosclerosis	0.00108	0.00412	CcSEcCtD
Palonosetron—Erythema—Niacin—atherosclerosis	0.00108	0.00412	CcSEcCtD
Palonosetron—Alopecia—Pravastatin—atherosclerosis	0.00108	0.00412	CcSEcCtD
Palonosetron—Myalgia—Lovastatin—atherosclerosis	0.00107	0.00409	CcSEcCtD
Palonosetron—Arthralgia—Lovastatin—atherosclerosis	0.00107	0.00409	CcSEcCtD
Palonosetron—Anxiety—Lovastatin—atherosclerosis	0.00107	0.00407	CcSEcCtD
Palonosetron—Dyspepsia—Rosuvastatin—atherosclerosis	0.00107	0.00407	CcSEcCtD
Palonosetron—Hypertension—Ezetimibe—atherosclerosis	0.00107	0.00406	CcSEcCtD
Palonosetron—Flatulence—Niacin—atherosclerosis	0.00107	0.00406	CcSEcCtD
Palonosetron—Discomfort—Lovastatin—atherosclerosis	0.00106	0.00404	CcSEcCtD
Palonosetron—Myalgia—Ezetimibe—atherosclerosis	0.00105	0.00401	CcSEcCtD
Palonosetron—Arthralgia—Ezetimibe—atherosclerosis	0.00105	0.00401	CcSEcCtD
Palonosetron—Flatulence—Pravastatin—atherosclerosis	0.00105	0.004	CcSEcCtD
Palonosetron—Dry mouth—Lovastatin—atherosclerosis	0.00105	0.004	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00105	0.00398	CcSEcCtD
Palonosetron—Dysgeusia—Pravastatin—atherosclerosis	0.00104	0.00397	CcSEcCtD
Palonosetron—Discomfort—Ezetimibe—atherosclerosis	0.00104	0.00396	CcSEcCtD
Palonosetron—Pain—Rosuvastatin—atherosclerosis	0.00104	0.00395	CcSEcCtD
Palonosetron—Constipation—Rosuvastatin—atherosclerosis	0.00104	0.00395	CcSEcCtD
Palonosetron—Dry mouth—Ezetimibe—atherosclerosis	0.00103	0.00392	CcSEcCtD
Palonosetron—Anaphylactic shock—Lovastatin—atherosclerosis	0.00103	0.00392	CcSEcCtD
Palonosetron—Infection—Lovastatin—atherosclerosis	0.00102	0.00389	CcSEcCtD
Palonosetron—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00101	0.00384	CcSEcCtD
Palonosetron—Arthralgia—Simvastatin—atherosclerosis	0.001	0.00382	CcSEcCtD
Palonosetron—Myalgia—Simvastatin—atherosclerosis	0.001	0.00382	CcSEcCtD
Palonosetron—Infection—Ezetimibe—atherosclerosis	0.001	0.00382	CcSEcCtD
Palonosetron—Anxiety—Simvastatin—atherosclerosis	0.001	0.00381	CcSEcCtD
Palonosetron—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000992	0.00378	CcSEcCtD
Palonosetron—Discomfort—Simvastatin—atherosclerosis	0.000991	0.00378	CcSEcCtD
Palonosetron—Nervous system disorder—Ezetimibe—atherosclerosis	0.000989	0.00377	CcSEcCtD
Palonosetron—Anaemia—Pravastatin—atherosclerosis	0.000985	0.00375	CcSEcCtD
Palonosetron—Anorexia—Lovastatin—atherosclerosis	0.00098	0.00373	CcSEcCtD
Palonosetron—Skin disorder—Ezetimibe—atherosclerosis	0.00098	0.00373	CcSEcCtD
Palonosetron—Anaphylactic shock—Simvastatin—atherosclerosis	0.000962	0.00366	CcSEcCtD
Palonosetron—Abdominal pain—Rosuvastatin—atherosclerosis	0.000959	0.00365	CcSEcCtD
Palonosetron—Infection—Simvastatin—atherosclerosis	0.000956	0.00364	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000937	0.00357	CcSEcCtD
Palonosetron—Insomnia—Lovastatin—atherosclerosis	0.00093	0.00354	CcSEcCtD
Palonosetron—Paraesthesia—Lovastatin—atherosclerosis	0.000923	0.00352	CcSEcCtD
Palonosetron—Arthralgia—Niacin—atherosclerosis	0.000921	0.00351	CcSEcCtD
Palonosetron—Myalgia—Niacin—atherosclerosis	0.000921	0.00351	CcSEcCtD
Palonosetron—Hypertension—Pravastatin—atherosclerosis	0.00092	0.0035	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000919	0.0035	CcSEcCtD
Palonosetron—Anorexia—Simvastatin—atherosclerosis	0.000917	0.00349	CcSEcCtD
Palonosetron—Dyspnoea—Lovastatin—atherosclerosis	0.000917	0.00349	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000915	0.00348	CcSEcCtD
Palonosetron—Insomnia—Ezetimibe—atherosclerosis	0.000912	0.00347	CcSEcCtD
Palonosetron—Arthralgia—Pravastatin—atherosclerosis	0.000907	0.00345	CcSEcCtD
Palonosetron—Myalgia—Pravastatin—atherosclerosis	0.000907	0.00345	CcSEcCtD
Palonosetron—Paraesthesia—Ezetimibe—atherosclerosis	0.000906	0.00345	CcSEcCtD
Palonosetron—Dyspepsia—Lovastatin—atherosclerosis	0.000905	0.00345	CcSEcCtD
Palonosetron—Anxiety—Pravastatin—atherosclerosis	0.000904	0.00344	CcSEcCtD
Palonosetron—Dry mouth—Niacin—atherosclerosis	0.000901	0.00343	CcSEcCtD
Palonosetron—Dyspnoea—Ezetimibe—atherosclerosis	0.000899	0.00342	CcSEcCtD
Palonosetron—Discomfort—Pravastatin—atherosclerosis	0.000896	0.00341	CcSEcCtD
Palonosetron—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000894	0.0034	CcSEcCtD
Palonosetron—Decreased appetite—Lovastatin—atherosclerosis	0.000894	0.0034	CcSEcCtD
Palonosetron—Dyspepsia—Ezetimibe—atherosclerosis	0.000888	0.00338	CcSEcCtD
Palonosetron—Fatigue—Lovastatin—atherosclerosis	0.000887	0.00338	CcSEcCtD
Palonosetron—Anaphylactic shock—Niacin—atherosclerosis	0.000883	0.00336	CcSEcCtD
Palonosetron—Constipation—Lovastatin—atherosclerosis	0.000879	0.00335	CcSEcCtD
Palonosetron—Pain—Lovastatin—atherosclerosis	0.000879	0.00335	CcSEcCtD
Palonosetron—Decreased appetite—Ezetimibe—atherosclerosis	0.000877	0.00334	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000876	0.00334	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000871	0.00332	CcSEcCtD
Palonosetron—Asthenia—Rosuvastatin—atherosclerosis	0.000871	0.00332	CcSEcCtD
Palonosetron—Insomnia—Simvastatin—atherosclerosis	0.00087	0.00331	CcSEcCtD
Palonosetron—Anaphylactic shock—Pravastatin—atherosclerosis	0.00087	0.00331	CcSEcCtD
Palonosetron—Fatigue—Ezetimibe—atherosclerosis	0.00087	0.00331	CcSEcCtD
Palonosetron—Shock—Niacin—atherosclerosis	0.000869	0.00331	CcSEcCtD
Palonosetron—Infection—Pravastatin—atherosclerosis	0.000864	0.00329	CcSEcCtD
Palonosetron—Paraesthesia—Simvastatin—atherosclerosis	0.000864	0.00329	CcSEcCtD
Palonosetron—Pain—Ezetimibe—atherosclerosis	0.000863	0.00328	CcSEcCtD
Palonosetron—Constipation—Ezetimibe—atherosclerosis	0.000863	0.00328	CcSEcCtD
Palonosetron—Tachycardia—Niacin—atherosclerosis	0.000862	0.00328	CcSEcCtD
Palonosetron—Pruritus—Rosuvastatin—atherosclerosis	0.000859	0.00327	CcSEcCtD
Palonosetron—Skin disorder—Niacin—atherosclerosis	0.000858	0.00327	CcSEcCtD
Palonosetron—Dyspnoea—Simvastatin—atherosclerosis	0.000858	0.00327	CcSEcCtD
Palonosetron—Dyspepsia—Simvastatin—atherosclerosis	0.000847	0.00322	CcSEcCtD
Palonosetron—Anorexia—Niacin—atherosclerosis	0.000842	0.00321	CcSEcCtD
Palonosetron—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000841	0.0032	CcSEcCtD
Palonosetron—Decreased appetite—Simvastatin—atherosclerosis	0.000836	0.00318	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000831	0.00316	CcSEcCtD
Palonosetron—Diarrhoea—Rosuvastatin—atherosclerosis	0.00083	0.00316	CcSEcCtD
Palonosetron—Fatigue—Simvastatin—atherosclerosis	0.000829	0.00316	CcSEcCtD
Palonosetron—Anorexia—Pravastatin—atherosclerosis	0.000829	0.00316	CcSEcCtD
Palonosetron—Hypotension—Niacin—atherosclerosis	0.000825	0.00314	CcSEcCtD
Palonosetron—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000825	0.00314	CcSEcCtD
Palonosetron—Pain—Simvastatin—atherosclerosis	0.000823	0.00313	CcSEcCtD
Palonosetron—Constipation—Simvastatin—atherosclerosis	0.000823	0.00313	CcSEcCtD
Palonosetron—Body temperature increased—Lovastatin—atherosclerosis	0.000813	0.0031	CcSEcCtD
Palonosetron—Abdominal pain—Lovastatin—atherosclerosis	0.000813	0.0031	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000805	0.00306	CcSEcCtD
Palonosetron—Dizziness—Rosuvastatin—atherosclerosis	0.000803	0.00306	CcSEcCtD
Palonosetron—Insomnia—Niacin—atherosclerosis	0.000799	0.00304	CcSEcCtD
Palonosetron—Abdominal pain—Ezetimibe—atherosclerosis	0.000797	0.00304	CcSEcCtD
Palonosetron—Body temperature increased—Ezetimibe—atherosclerosis	0.000797	0.00304	CcSEcCtD
Palonosetron—Paraesthesia—Niacin—atherosclerosis	0.000793	0.00302	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000792	0.00302	CcSEcCtD
Palonosetron—Dyspnoea—Niacin—atherosclerosis	0.000787	0.003	CcSEcCtD
Palonosetron—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000787	0.003	CcSEcCtD
Palonosetron—Insomnia—Pravastatin—atherosclerosis	0.000787	0.003	CcSEcCtD
Palonosetron—Somnolence—Niacin—atherosclerosis	0.000785	0.00299	CcSEcCtD
Palonosetron—Paraesthesia—Pravastatin—atherosclerosis	0.000781	0.00297	CcSEcCtD
Palonosetron—Dyspepsia—Niacin—atherosclerosis	0.000778	0.00296	CcSEcCtD
Palonosetron—Dyspnoea—Pravastatin—atherosclerosis	0.000775	0.00295	CcSEcCtD
Palonosetron—Decreased appetite—Niacin—atherosclerosis	0.000768	0.00292	CcSEcCtD
Palonosetron—Dyspepsia—Pravastatin—atherosclerosis	0.000766	0.00292	CcSEcCtD
Palonosetron—Rash—Rosuvastatin—atherosclerosis	0.000765	0.00291	CcSEcCtD
Palonosetron—Dermatitis—Rosuvastatin—atherosclerosis	0.000764	0.00291	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Niacin—atherosclerosis	0.000763	0.0029	CcSEcCtD
Palonosetron—Abdominal pain—Simvastatin—atherosclerosis	0.00076	0.0029	CcSEcCtD
Palonosetron—Body temperature increased—Simvastatin—atherosclerosis	0.00076	0.0029	CcSEcCtD
Palonosetron—Headache—Rosuvastatin—atherosclerosis	0.00076	0.0029	CcSEcCtD
Palonosetron—Hypersensitivity—Lovastatin—atherosclerosis	0.000758	0.00289	CcSEcCtD
Palonosetron—Decreased appetite—Pravastatin—atherosclerosis	0.000756	0.00288	CcSEcCtD
Palonosetron—Pain—Niacin—atherosclerosis	0.000755	0.00288	CcSEcCtD
Palonosetron—Fatigue—Pravastatin—atherosclerosis	0.00075	0.00286	CcSEcCtD
Palonosetron—Pain—Pravastatin—atherosclerosis	0.000744	0.00283	CcSEcCtD
Palonosetron—Constipation—Pravastatin—atherosclerosis	0.000744	0.00283	CcSEcCtD
Palonosetron—Hypersensitivity—Ezetimibe—atherosclerosis	0.000743	0.00283	CcSEcCtD
Palonosetron—Asthenia—Lovastatin—atherosclerosis	0.000738	0.00281	CcSEcCtD
Palonosetron—Pruritus—Lovastatin—atherosclerosis	0.000728	0.00277	CcSEcCtD
Palonosetron—Asthenia—Ezetimibe—atherosclerosis	0.000724	0.00276	CcSEcCtD
Palonosetron—Gastrointestinal pain—Niacin—atherosclerosis	0.000722	0.00275	CcSEcCtD
Palonosetron—Nausea—Rosuvastatin—atherosclerosis	0.000721	0.00274	CcSEcCtD
Palonosetron—Pruritus—Ezetimibe—atherosclerosis	0.000714	0.00272	CcSEcCtD
Palonosetron—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000711	0.00271	CcSEcCtD
Palonosetron—Hypersensitivity—Simvastatin—atherosclerosis	0.000709	0.0027	CcSEcCtD
Palonosetron—Diarrhoea—Lovastatin—atherosclerosis	0.000704	0.00268	CcSEcCtD
Palonosetron—Body temperature increased—Niacin—atherosclerosis	0.000698	0.00266	CcSEcCtD
Palonosetron—Abdominal pain—Niacin—atherosclerosis	0.000698	0.00266	CcSEcCtD
Palonosetron—Asthenia—Simvastatin—atherosclerosis	0.00069	0.00263	CcSEcCtD
Palonosetron—Diarrhoea—Ezetimibe—atherosclerosis	0.00069	0.00263	CcSEcCtD
Palonosetron—Abdominal pain—Pravastatin—atherosclerosis	0.000688	0.00262	CcSEcCtD
Palonosetron—Body temperature increased—Pravastatin—atherosclerosis	0.000688	0.00262	CcSEcCtD
Palonosetron—Pruritus—Simvastatin—atherosclerosis	0.000681	0.00259	CcSEcCtD
Palonosetron—Dizziness—Lovastatin—atherosclerosis	0.00068	0.00259	CcSEcCtD
Palonosetron—Dizziness—Ezetimibe—atherosclerosis	0.000667	0.00254	CcSEcCtD
Palonosetron—Diarrhoea—Simvastatin—atherosclerosis	0.000658	0.00251	CcSEcCtD
Palonosetron—Vomiting—Lovastatin—atherosclerosis	0.000654	0.00249	CcSEcCtD
Palonosetron—Hypersensitivity—Niacin—atherosclerosis	0.000651	0.00248	CcSEcCtD
Palonosetron—Rash—Lovastatin—atherosclerosis	0.000648	0.00247	CcSEcCtD
Palonosetron—Dermatitis—Lovastatin—atherosclerosis	0.000648	0.00247	CcSEcCtD
Palonosetron—Headache—Lovastatin—atherosclerosis	0.000644	0.00245	CcSEcCtD
Palonosetron—Vomiting—Ezetimibe—atherosclerosis	0.000641	0.00244	CcSEcCtD
Palonosetron—Hypersensitivity—Pravastatin—atherosclerosis	0.000641	0.00244	CcSEcCtD
Palonosetron—Dizziness—Simvastatin—atherosclerosis	0.000636	0.00242	CcSEcCtD
Palonosetron—Rash—Ezetimibe—atherosclerosis	0.000636	0.00242	CcSEcCtD
Palonosetron—Dermatitis—Ezetimibe—atherosclerosis	0.000635	0.00242	CcSEcCtD
Palonosetron—Asthenia—Niacin—atherosclerosis	0.000634	0.00241	CcSEcCtD
Palonosetron—Headache—Ezetimibe—atherosclerosis	0.000632	0.00241	CcSEcCtD
Palonosetron—Pruritus—Niacin—atherosclerosis	0.000625	0.00238	CcSEcCtD
Palonosetron—Asthenia—Pravastatin—atherosclerosis	0.000624	0.00238	CcSEcCtD
Palonosetron—Pruritus—Pravastatin—atherosclerosis	0.000615	0.00234	CcSEcCtD
Palonosetron—Vomiting—Simvastatin—atherosclerosis	0.000612	0.00233	CcSEcCtD
Palonosetron—Nausea—Lovastatin—atherosclerosis	0.000611	0.00233	CcSEcCtD
Palonosetron—Rash—Simvastatin—atherosclerosis	0.000607	0.00231	CcSEcCtD
Palonosetron—Dermatitis—Simvastatin—atherosclerosis	0.000606	0.00231	CcSEcCtD
Palonosetron—Diarrhoea—Niacin—atherosclerosis	0.000604	0.0023	CcSEcCtD
Palonosetron—Headache—Simvastatin—atherosclerosis	0.000603	0.00229	CcSEcCtD
Palonosetron—Nausea—Ezetimibe—atherosclerosis	0.000599	0.00228	CcSEcCtD
Palonosetron—Diarrhoea—Pravastatin—atherosclerosis	0.000595	0.00227	CcSEcCtD
Palonosetron—Dizziness—Niacin—atherosclerosis	0.000584	0.00222	CcSEcCtD
Palonosetron—Dizziness—Pravastatin—atherosclerosis	0.000575	0.00219	CcSEcCtD
Palonosetron—Nausea—Simvastatin—atherosclerosis	0.000571	0.00218	CcSEcCtD
Palonosetron—Vomiting—Niacin—atherosclerosis	0.000562	0.00214	CcSEcCtD
Palonosetron—Rash—Niacin—atherosclerosis	0.000557	0.00212	CcSEcCtD
Palonosetron—Dermatitis—Niacin—atherosclerosis	0.000556	0.00212	CcSEcCtD
Palonosetron—Headache—Niacin—atherosclerosis	0.000553	0.00211	CcSEcCtD
Palonosetron—Vomiting—Pravastatin—atherosclerosis	0.000553	0.00211	CcSEcCtD
Palonosetron—Rash—Pravastatin—atherosclerosis	0.000548	0.00209	CcSEcCtD
Palonosetron—Dermatitis—Pravastatin—atherosclerosis	0.000548	0.00209	CcSEcCtD
Palonosetron—Headache—Pravastatin—atherosclerosis	0.000545	0.00207	CcSEcCtD
Palonosetron—Nausea—Niacin—atherosclerosis	0.000525	0.002	CcSEcCtD
Palonosetron—Nausea—Pravastatin—atherosclerosis	0.000517	0.00197	CcSEcCtD
Palonosetron—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000116	0.00778	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.000116	0.00777	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000113	0.00758	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000112	0.00756	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000107	0.00719	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000106	0.0071	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.000104	0.00698	CbGpPWpGaD
Palonosetron—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000104	0.00698	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—EDN1—atherosclerosis	0.000104	0.00696	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.0001	0.00672	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—APOE—atherosclerosis	9.95e-05	0.00669	CbGpPWpGaD
Palonosetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	9.89e-05	0.00665	CbGpPWpGaD
Palonosetron—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	9.76e-05	0.00656	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	8.71e-05	0.00585	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	8.68e-05	0.00583	CbGpPWpGaD
Palonosetron—CYP1A2—Estrogen Receptor Pathway—STAT3—atherosclerosis	8.56e-05	0.00575	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—APOE—atherosclerosis	8.43e-05	0.00566	CbGpPWpGaD
Palonosetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	8.02e-05	0.00539	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	7.82e-05	0.00526	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	7.73e-05	0.00519	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL1B—atherosclerosis	7.41e-05	0.00498	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—CETP—atherosclerosis	7.41e-05	0.00498	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP7A1—atherosclerosis	7.05e-05	0.00474	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP7A1—atherosclerosis	6.95e-05	0.00467	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—LPL—atherosclerosis	6.95e-05	0.00467	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	6.91e-05	0.00465	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	6.61e-05	0.00444	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—PLAT—atherosclerosis	6.53e-05	0.00439	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—CYP27A1—atherosclerosis	6.52e-05	0.00438	CbGpPWpGaD
Palonosetron—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	6.46e-05	0.00434	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—CYP27A1—atherosclerosis	6.43e-05	0.00432	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—GPX1—atherosclerosis	6.34e-05	0.00426	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	6.28e-05	0.00422	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	6.04e-05	0.00406	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP7A1—atherosclerosis	5.97e-05	0.00401	CbGpPWpGaD
Palonosetron—CYP2D6—Melatonin metabolism and effects—NFKB1—atherosclerosis	5.92e-05	0.00398	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP7A1—atherosclerosis	5.89e-05	0.00396	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	5.56e-05	0.00374	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—PLG—atherosclerosis	5.55e-05	0.00373	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—CYP27A1—atherosclerosis	5.52e-05	0.00371	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—CYP27A1—atherosclerosis	5.44e-05	0.00366	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—TNF—atherosclerosis	5.38e-05	0.00361	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—HMOX1—atherosclerosis	5.12e-05	0.00344	CbGpPWpGaD
Palonosetron—CYP1A2—Melatonin metabolism and effects—NFKB1—atherosclerosis	5.01e-05	0.00337	CbGpPWpGaD
Palonosetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	4.99e-05	0.00335	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—APOB—atherosclerosis	4.91e-05	0.0033	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	4.61e-05	0.0031	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	4.55e-05	0.00305	CbGpPWpGaD
Palonosetron—HTR3A—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.34e-05	0.00292	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	4.26e-05	0.00286	CbGpPWpGaD
Palonosetron—CYP1A2—Phase II conjugation—GSTM1—atherosclerosis	4.21e-05	0.00283	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	4.2e-05	0.00282	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	4.16e-05	0.0028	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—PPARA—atherosclerosis	4.14e-05	0.00278	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—atherosclerosis	3.99e-05	0.00268	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	3.93e-05	0.00264	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.88e-05	0.00261	CbGpPWpGaD
Palonosetron—CYP1A2—Arachidonic acid metabolism—PTGS2—atherosclerosis	3.74e-05	0.00251	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	3.71e-05	0.0025	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	3.69e-05	0.00248	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	3.47e-05	0.00233	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	3.2e-05	0.00215	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	3.2e-05	0.00215	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	3.15e-05	0.00211	CbGpPWpGaD
Palonosetron—HTR3A—Transmembrane transport of small molecules—ALB—atherosclerosis	3.08e-05	0.00207	CbGpPWpGaD
Palonosetron—CYP2D6—Biological oxidations—GSTM1—atherosclerosis	2.91e-05	0.00196	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	2.89e-05	0.00194	CbGpPWpGaD
Palonosetron—CYP2D6—Metapathway biotransformation—GSTM1—atherosclerosis	2.87e-05	0.00193	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	2.7e-05	0.00181	CbGpPWpGaD
Palonosetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	2.7e-05	0.00181	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	2.53e-05	0.0017	CbGpPWpGaD
Palonosetron—CYP1A2—Biological oxidations—GSTM1—atherosclerosis	2.47e-05	0.00166	CbGpPWpGaD
Palonosetron—CYP1A2—Metapathway biotransformation—GSTM1—atherosclerosis	2.43e-05	0.00163	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	2.38e-05	0.0016	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	2.38e-05	0.0016	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	2.33e-05	0.00157	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	2.29e-05	0.00154	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	2.12e-05	0.00142	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LDLRAP1—atherosclerosis	2.06e-05	0.00139	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	2.01e-05	0.00135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	2.01e-05	0.00135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	2.01e-05	0.00135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	2.01e-05	0.00135	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	1.99e-05	0.00133	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLTP—atherosclerosis	1.94e-05	0.0013	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	1.92e-05	0.00129	CbGpPWpGaD
Palonosetron—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.9e-05	0.00128	CbGpPWpGaD
Palonosetron—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.88e-05	0.00126	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	1.84e-05	0.00124	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	1.77e-05	0.00119	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LDLRAP1—atherosclerosis	1.75e-05	0.00117	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	1.71e-05	0.00115	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCG8—atherosclerosis	1.68e-05	0.00113	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LTA4H—atherosclerosis	1.68e-05	0.00113	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLTP—atherosclerosis	1.64e-05	0.0011	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.52e-05	0.00102	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.51e-05	0.00102	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.5e-05	0.00101	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.47e-05	0.000987	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LTA4H—atherosclerosis	1.43e-05	0.000958	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCG8—atherosclerosis	1.43e-05	0.000958	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.41e-05	0.000946	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.35e-05	0.000907	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCG1—atherosclerosis	1.33e-05	0.000894	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.33e-05	0.000893	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLTP—atherosclerosis	1.27e-05	0.000853	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—FABP4—atherosclerosis	1.25e-05	0.00084	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LCAT—atherosclerosis	1.25e-05	0.00084	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOA4—atherosclerosis	1.23e-05	0.000825	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.21e-05	0.00081	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.18e-05	0.000796	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.13e-05	0.000757	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.11e-05	0.000749	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.1e-05	0.000739	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.1e-05	0.000739	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LCAT—atherosclerosis	1.06e-05	0.000712	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—FABP4—atherosclerosis	1.06e-05	0.000712	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOA2—atherosclerosis	1.06e-05	0.00071	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.06e-05	0.00071	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.06e-05	0.00071	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.06e-05	0.00071	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.04e-05	0.000701	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOA4—atherosclerosis	1.04e-05	0.000699	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.02e-05	0.000686	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LPA—atherosclerosis	1.01e-05	0.000677	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—BGN—atherosclerosis	9.76e-06	0.000656	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	9.73e-06	0.000654	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOA5—atherosclerosis	9.66e-06	0.000649	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CYP27A1—atherosclerosis	9.44e-06	0.000634	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	9.3e-06	0.000625	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	9.29e-06	0.000625	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	9.07e-06	0.000609	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALOX5—atherosclerosis	8.98e-06	0.000604	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALOX15—atherosclerosis	8.95e-06	0.000601	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOA2—atherosclerosis	8.95e-06	0.000601	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	8.95e-06	0.000601	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	8.95e-06	0.000601	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCG5—atherosclerosis	8.84e-06	0.000594	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.83e-06	0.000593	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.69e-06	0.000584	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LPA—atherosclerosis	8.54e-06	0.000574	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—BGN—atherosclerosis	8.27e-06	0.000556	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	8.21e-06	0.000552	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOA5—atherosclerosis	8.19e-06	0.00055	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—FABP4—atherosclerosis	8.17e-06	0.000549	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LCAT—atherosclerosis	8.17e-06	0.000549	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NAMPT—atherosclerosis	8.06e-06	0.000541	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOA4—atherosclerosis	8.02e-06	0.000539	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LIPC—atherosclerosis	8.01e-06	0.000538	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOC3—atherosclerosis	7.96e-06	0.000535	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.95e-06	0.000534	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LDLR—atherosclerosis	7.91e-06	0.000531	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.88e-06	0.00053	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	7.88e-06	0.00053	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.79e-06	0.000524	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CETP—atherosclerosis	7.72e-06	0.000519	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.72e-06	0.000519	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.7e-06	0.000518	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALOX5—atherosclerosis	7.61e-06	0.000511	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.4e-06	0.000497	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.29e-06	0.00049	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.03e-06	0.000472	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMGCR—atherosclerosis	6.99e-06	0.000469	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.91e-06	0.000464	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.91e-06	0.000464	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.91e-06	0.000464	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOA2—atherosclerosis	6.91e-06	0.000464	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NAMPT—atherosclerosis	6.83e-06	0.000459	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.82e-06	0.000458	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.79e-06	0.000456	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LIPC—atherosclerosis	6.78e-06	0.000456	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOC3—atherosclerosis	6.74e-06	0.000453	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LDLR—atherosclerosis	6.7e-06	0.00045	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LPA—atherosclerosis	6.59e-06	0.000443	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CETP—atherosclerosis	6.54e-06	0.00044	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—BGN—atherosclerosis	6.38e-06	0.000429	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOA5—atherosclerosis	6.32e-06	0.000425	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—SCARB1—atherosclerosis	6.27e-06	0.000421	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.23e-06	0.000418	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.1e-06	0.00041	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.08e-06	0.000409	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMGCR—atherosclerosis	5.92e-06	0.000398	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.87e-06	0.000395	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.34e-06	0.000359	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.34e-06	0.000359	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.27e-06	0.000354	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.27e-06	0.000354	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LIPC—atherosclerosis	5.23e-06	0.000352	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOC3—atherosclerosis	5.2e-06	0.00035	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LDLR—atherosclerosis	5.17e-06	0.000347	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOB—atherosclerosis	5.12e-06	0.000344	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CETP—atherosclerosis	5.05e-06	0.000339	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.98e-06	0.000335	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—LPL—atherosclerosis	4.89e-06	0.000328	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.84e-06	0.000325	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—GPX1—atherosclerosis	4.77e-06	0.00032	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CD36—atherosclerosis	4.64e-06	0.000312	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.57e-06	0.000307	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.53e-06	0.000304	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.4e-06	0.000296	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOB—atherosclerosis	4.33e-06	0.000291	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARA—atherosclerosis	4.32e-06	0.00029	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.22e-06	0.000283	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AGT—atherosclerosis	4.18e-06	0.000281	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—LPL—atherosclerosis	4.14e-06	0.000278	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOE—atherosclerosis	4.1e-06	0.000275	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.07e-06	0.000274	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—CAV1—atherosclerosis	4.06e-06	0.000273	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—APOA1—atherosclerosis	4.05e-06	0.000272	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—GPX1—atherosclerosis	4.04e-06	0.000271	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CD36—atherosclerosis	3.93e-06	0.000264	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.73e-06	0.00025	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.7e-06	0.000248	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARA—atherosclerosis	3.66e-06	0.000246	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PPARG—atherosclerosis	3.57e-06	0.00024	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AGT—atherosclerosis	3.54e-06	0.000238	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—INS—atherosclerosis	3.5e-06	0.000235	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.49e-06	0.000235	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOE—atherosclerosis	3.47e-06	0.000233	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—CAV1—atherosclerosis	3.44e-06	0.000231	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—APOA1—atherosclerosis	3.43e-06	0.00023	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOB—atherosclerosis	3.35e-06	0.000225	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.25e-06	0.000219	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—ALB—atherosclerosis	3.21e-06	0.000216	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—LPL—atherosclerosis	3.19e-06	0.000215	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.13e-06	0.00021	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—GPX1—atherosclerosis	3.12e-06	0.000209	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—NOS3—atherosclerosis	3.07e-06	0.000206	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CD36—atherosclerosis	3.04e-06	0.000204	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PPARG—atherosclerosis	3.02e-06	0.000203	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—INS—atherosclerosis	2.96e-06	0.000199	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.88e-06	0.000193	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARA—atherosclerosis	2.82e-06	0.00019	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.81e-06	0.000189	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AGT—atherosclerosis	2.73e-06	0.000184	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—ALB—atherosclerosis	2.72e-06	0.000183	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOE—atherosclerosis	2.68e-06	0.00018	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—CAV1—atherosclerosis	2.65e-06	0.000178	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—APOA1—atherosclerosis	2.65e-06	0.000178	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—NOS3—atherosclerosis	2.6e-06	0.000175	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.42e-06	0.000162	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.38e-06	0.00016	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PPARG—atherosclerosis	2.33e-06	0.000157	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—INS—atherosclerosis	2.29e-06	0.000154	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—ALB—atherosclerosis	2.1e-06	0.000141	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—NOS3—atherosclerosis	2.01e-06	0.000135	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.83e-06	0.000123	CbGpPWpGaD
Palonosetron—CYP2D6—Metabolism—AKT1—atherosclerosis	1.41e-06	9.48e-05	CbGpPWpGaD
Palonosetron—CYP1A2—Metabolism—AKT1—atherosclerosis	1.19e-06	8.03e-05	CbGpPWpGaD
Palonosetron—CYP3A4—Metabolism—AKT1—atherosclerosis	9.22e-07	6.2e-05	CbGpPWpGaD
